Literature DB >> 16651058

Quality of life in patients with atrial fibrillation: a systematic review.

Graham Thrall1, Deirdre Lane, Douglas Carroll, Gregory Y H Lip.   

Abstract

The impact of atrial fibrillation (AF) on patients' quality of life (QoL) has yet to be fully elucidated in a systematic manner. This article examines QoL in "general" patients with AF as well as the effects that rate and/or rhythm-control interventions have on QoL. Patients with AF have significantly poorer QoL compared with healthy controls, the general population, and other patients with coronary heart disease. Studies examining rate or rhythm-control strategies alone demonstrate improved QoL after intervention. Three of the four large randomized control trials (STAF, PIAF, RACE) comparing rate versus rhythm control demonstrated a greater improvement in QoL in patients receiving rate control. However, the AFFIRM trial revealed a similar improvement in QoL for both rate and rhythm-control groups. The data, although frequently compromised by various methodologic weaknesses, suggest that patients with AF have impaired QoL, and that QoL can be significantly improved through rate or rhythm-control strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651058     DOI: 10.1016/j.amjmed.2005.10.057

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  156 in total

Review 1.  Atrial fibrillation (chronic).

Authors:  Deirdre A Lane; Stavros Apostolakis; Christopher J Boos; Gregory Y H Lip
Journal:  BMJ Clin Evid       Date:  2011-11-10

Review 2.  Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.

Authors:  F De Rienzo; R R Gabdoulline; R C Wade; M Sola; M C Menziani
Journal:  Cell Mol Life Sci       Date:  2004-05       Impact factor: 9.261

Review 3.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

Review 4.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

5.  [Management and therapy of atrial fibrillation in geriatric patients].

Authors:  M Gosch; R E Roller; B Böhmdorfer; U Benvenuti-Falger; B Iglseder; M Lechleitner; U Sommeregger; P Dovjak
Journal:  Z Gerontol Geriatr       Date:  2012-01       Impact factor: 1.281

Review 6.  [Atrial fibrillation].

Authors:  M G Hennersdorf; B E Strauer
Journal:  Internist (Berl)       Date:  2006-10       Impact factor: 0.743

7.  Atrial fibrillation--the growing epidemic.

Authors:  Gregory Y H Lip; Puneet Kakar; Timothy Watson
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

8.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

9.  Impact of epicardial ablation of concomitant atrial fibrillation on atrial natriuretic peptide levels and atrial function in 6 months follow-up: does preoperative ANP level predict outcome of ablation?

Authors:  Marek Pizon; Norbert Friedel; Monika Pizon; Miriam Freundt; Michael Weyand; Richard Feyrer
Journal:  J Cardiothorac Surg       Date:  2013-11-28       Impact factor: 1.637

10.  Left atrial size and function in a South Asian population and their potential influence on the risk of atrial fibrillation.

Authors:  James O'Neill; Peter P Swoboda; Sven Plein; Muzahir H Tayebjee
Journal:  Clin Cardiol       Date:  2018-10-21       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.